Inhibition of Corneal Neovascularization with a Nutrient Mixture Containing Lysine, Proline, Ascorbic Acid, and Green Tea Extract

Archives of Medical Research

Volumn 38, Issue 7, 2007, Pages 789-791

  Shakiba, Yadollah ^a   Mostafaie, Ali ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ascorbic acid; Cornea; Green tea extract; Lysine; Neovascularization; Proline

Indexed keywords

ASCORBIC ACID; GREEN TEA EXTRACT; LYSINE; MATRIX METALLOPROTEINASE; PEGAPTANIB; PROLINE; RANIBIZUMAB; VASCULOTROPIN;

ARTICLE; CELL MIGRATION; CORNEA NEOVASCULARIZATION; DRUG EFFECT; DRUG EFFICACY; DRUG MIXTURE; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME RELEASE; PROTEIN SECRETION;

ADMINISTRATION, TOPICAL; ANIMALS; ASCORBIC ACID; CORNEAL NEOVASCULARIZATION; DEPRESSION, CHEMICAL; DRUG COMBINATIONS; HUMANS; LYSINE; MATRIX METALLOPROTEINASES; OPHTHALMIC SOLUTIONS; PHYTOTHERAPY; PLANT EXTRACTS; PROLINE; TEA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548435126     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.04.006     Document Type: Article

References (46)

1. Lee P., Wang C.C., and Adamis A.P. Ocular neovascularization. An epidemiologic review. Surv Ophthalmol 433 (1998) 245-269
2. Alldredge O.C., and Krachmer J.H. Clinical types of corneal transplant rejection their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol 994 (1981) 599-604
3. Chang J.H., Gabison E.E., Kato T., and Azar D.T. Corneal neovascularization. Curr Opin Ophthalmol 124 (2001) 242-249
4. Ben Ezra D., Griffin B.W., Maftzir G., Sharif N.A., and Clark A.F. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci 3810 (1997) 1954-1962
5. Crum R., Szabo S., and Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230 (1986) 1375-1378
6. Tanaka N.G., Sakamoto N., Korenaga H., Inoue K., Ogawa H., and Osada Y. The combination of a bacterial polysaccharide and tamoxifen inhibits angiogenesis and tumour growth. Int J Radiat Biol 601-2 (1991) 79-83
7. Murata M., Nakagawa M., and Takahashi S. Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas. Graefes Arch Clin Exp Ophthalmol 2359 (1997) 584-589
8. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348 (1990) 555-557
9. Kenyon B.M., Browne F., and D'Amato R.J. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 646 (1997) 971-978
10. Benelli U., Ross J.R., Nardi M., and Klintworth G.K. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci 382 (1997) 274-282
11. Huang A.J., Watson B.D., Hernandez E., and Tseng S.C. Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. Ophthalmology 952 (1998) 228-235
12. D'Amore P.A., and Thompson R.W. Mechanism of angiogenesis. Annu Rev Physiol 49 (1987) 453-464
13. Singh N., Amin S., Richter E., Rashid S., Scoglietti V., Jani P.D., et al. Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci 465 (2005) 1647-1652
14. Gan L., Fagerholm P., and Palmblad J. Vascular endothelial growth factor VEGF and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand 825 (2004) 557-563
15. Joussen A.M., Poulaki V., Mitsiades N., Stechschulte S.U., Kirchhof B., Dartt D.A., et al. VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol Vis Sci 441 (2003) 117-123
16. Zhou L.H., Xing Y.Q., Chen C.L., and Wang D.W. Antisense vascular endothelial growth factor suppressed corneal neovascularization in rats. Zhonghua Yan Ke Za Zhi 425 (2006) 426-430
17. Murata M., Takanami T., Shimizu S., Kubota Y., Horiuchi S., Habano W., et al. Inhibition of ocular angiogenesis by diced small interfering RNAs siRNAs specific to vascular endothelial growth factor VEGF. Curr Eye Res 312 (2006) 171-180
18. Lai C.M., Spilsbury K., Brankov M., Zaknich T., and Rakoczy P.E. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res 756 (2002) 625-634
19. Kim B., Tang Q., Biswas P.S., Xu J., Schiffelers R.M., Xie F.Y., et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 1656 (2004) 2177-2185
20. Chen J., Liu W., Liu Z., Chen L., Huang T., and Zhen H. Expression of vascular endothelial growth factor and its receptors flt-1. in morbid human corneas and investigation of its clinic importance. Yan Ke Xue Bao 184 (2002) 203-207
21. Amano S., Rohan R., Kuroki M., Tolentino M., and Adamis A.P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 391 (1998) 18-22
22. Adamis A.P., and Shima D.T. The role of vascular endothelial growth factor in ocular health and disease. Retina 252 (2005) 111-118
23. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 928 (2003) 827-839
24. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 217 (2001) 1104-1117
25. Mignatti P., and Rifkin D.B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 491-3 (1996) 117-137
26. Kato T., Kure T., Chang J.H., Gabison E.E., Itoh T., Itohara S., et al. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 5082 (2001) 187-190
27. Zhang H., Li C., and Baciu P.C. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis. Invest Ophthalmol Vis Sci 434 (2002) 955-962
28. Rigal-Sastourne J.C., Tixier J.M., Renard J.P., Maurin J.F., Pouliquen Y., and Legeais J.M. Corneal burns and matrix metalloproteinases MMP-2 and -9: the effects of human amniotic membrane transplantation. J Fr Ophtalmol 257 (2002) 685-693
29. Ma D.H., Chen J.K., Kim W.S., Hao Y.X., Wu H.C., Tsai R.J., et al. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res 336 (2001) 353-362
30. Kvanta A., Sarman S., Fagerholm P., Seregard S., and Steen B. Expression of matrix metalloproteinase-2 MMP-2. and vascular endothelial growth factor VEGF in inflammation-associated corneal neovascularization. Exp Eye Res 704 (2000) 419-428
31. Samolov B., Steen B., Seregard S., van der Ploeg I., Montan P., and Kvanta A. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp Eye Res 802 (2005) 159-166
32. Berglin L., Sarman S., van der Ploeg I., Steen B., Ming Y., Itohara S., et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci 441 (2003) 403-408
33. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-790. Oncol Rep 165 (2006) 943-947
34. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549. Exp Lung Res 329 (2006) 441-453
35. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Effect of ascorbic acid, lysine, proline, and green tea extract on human osteosarcoma cell line MNNG-HOS xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. Med Oncol 233 (2006) 411-418
36. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract. Int J Gynecol Cancer 163 (2006) 1241-1247
37. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Inhibition of malignant mesothelioma cell matrix metalloproteinase production and invasion by a novel nutrient mixture. Exp Lung Res 323 (2006) 69-79
38. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24. Int J Urol 134 (2006) 415-419
39. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080. Med Oncol 231 (2006) 105-111
40. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract. J Obstet Gynaecol Res 322 (2006) 148-154
41. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Natural nutrient mixture effectively reduces collagen matrix contraction driven by human uterine smooth muscle cells. J Obstet Gynaecol Res 321 (2006) 23-31
42. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058. In Vivo 201 (2006) 25-32
43. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. In Vivo 191 (2005) 179-183
44. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. Oncol Rep 133 (2005) 421-425
45. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells. Oncol Rep 146 (2005) 1399-1404
46. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., and Rath M. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis. Oncol Rep 144 (2005) 807-815